Improvements in transfection efficiency with chitosan modified poly(DL-lactide-co-glycolide) nanospheres prepared by the emulsion solvent diffusion method, for gene delivery

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 3, 2011, Pages 298-301

  Tahara, Kohei ^a,b   Sakai, Takeshi ^c   Yamamoto, Hiromitsu ^a   Takeuchi, Hirofumi ^c   Hirashima, Naohide ^b   Kawashima, Yoshiaki ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Chitosan; Emulsion solvent diffusion method; Nanosphere; Plasmid DNA; Poly(DL lactide co glycolide)

Indexed keywords

CHITOSAN; DEOXYRIBONUCLEASE; LUCIFERASE; NANOSPHERE; PLASMID DNA; POLYGLACTIN; SOLVENT;

ARTICLE; CELL LINE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DIFFUSION; DISPERSION; DNA TRANSFECTION; EMULSION; EMULSION SOLVENT DIFFUSION; ENZYME ACTIVITY; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; PARTICLE SIZE; REPORTER GENE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

CELL LINE, TUMOR; CHITOSAN; DIFFUSION; EMULSIONS; HUMANS; LACTIC ACID; NANOSPHERES; PLASMIDS; POLYGLYCOLIC ACID; SOLVENTS; TRANSFECTION;

EID: 79952424504     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.298     Document Type: Article

References (17)

1. Smith J., Zhang Y., Niven R., Adv. Drug Deliv. Rev., 26, 135-150 (1997).
2. Büning H., Nicklin S. A., Perabo L., Hallek M., Baker A. H., Curr. Opin. Mol. Ther., 5, 367-375 (2003).
3. Rudolph C., Plank C., Lausier J., Schillinger U., Müller R.H., Rosenecker J., J. Biol. Chem., 278, 11411-11418 (2003).
4. Wiethoff C. M., Koe J. G., Koe G. S., Middaugh C. R., J. Pharm. Sci., 93, 108-123 (2004).
5. Godbey W. T., Wu K. K., Mikos A. G., J. Controlled Release, 60, 149-160 (1999).
6. Maheshwari A., Mahato R. I., McGregor J., Han S., Samlowski W. E., Park J. S., Kim S. W., Mol. Ther., 2, 121-130 (2000).
7. Lobenberg R., Araujo L., Kreuter J., Eur. J. Pharm. Biopharm., 44, 127-132 (1997).
8. Prabha S., Zhou W. Z., Panyam J., Labhasetwar V., Int. J. Pharm., 244, 105-115 (2002).
9. Kawashima Y., Yamamoto H., Takeuchi H., Hino T., Niwa T., Eur. J. Pharm. Biopharm., 45, 41-48 (1998).
10. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Kawashima Y., Int. J. Pharm., 354, 210-216 (2008).
11. Tahara K., Yamamoto H., Hirashima N., Kawashima Y., Eur. J. Pharm. Biopharm., 75, 218-224 (2010).
12. Mao H. Q., Roy K., Troung-Le V. L., Janes K. A., Lin K. Y., Wang Y., August J. T., Leong K. W., J. Controlled Release, 70, 399-421 (2001).
13. Wang D., Robinson D. R., Kwon G. S., Samuel J., J. Controlled Release, 57, 9-18 (1999).
14. Kim I. S., Lee S. K., Park Y. M., Lee Y. B., Shin S. C., Lee K. C., Oh I. J., Int. J. Pharm., 298, 255-262 (2005).
15. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Hirashima N., Kawashima Y., Int. J. Pharm., 382, 198-204 (2009).
16. Ishii T., Okahata Y., Sato T., Biochim. Biophys. Acta, 1514, 51-64 (2001).
17. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).